4502 — Takeda Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual balance sheet for Takeda Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,002,820	875,000	553,704	472,889	405,589
Net Total Accounts Receivable
Net Total Receivables	812,714	724,377	681,693	697,610	725,254
Total Inventory
Total Other Current Assets
Total Current Assets	2,712,893	2,593,642	2,397,956	2,558,580	2,521,192
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,453,917	1,582,800	1,691,229	1,989,777	1,968,209
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	12,912,293	13,178,018	13,957,750	15,108,792	14,248,344
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,773,176	2,145,730	2,481,940	2,313,103	2,506,521
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	7,739,256	7,494,999	7,603,627	7,835,528	7,313,260
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	5,173,037	5,683,019	6,354,123	7,273,264	6,935,084
Total Liabilities & Shareholders' Equity	12,912,293	13,178,018	13,957,750	15,108,792	14,248,344
Total Common Shares Outstanding